loading

Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
19.47%
55.98
46.86 42.61 45.96 40.43
Operating Income/Loss
19.47%
-55.98
-46.86 -42.61 -45.96 -40.43
Income/Loss From Continuing Operations Before Tax
23.50%
-50.22
-40.67 -36.12 -40.80 -34.13
Income/Loss From Continuing Operations After Tax
23.51%
-50.23
-40.67 -36.12 -40.80 -34.13
Net Income/Loss
23.48%
-50.22
-40.67 -36.12 -40.80 -34.13
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.02%
1.0383
105.49 104.94 95.13 93.81
Diluted Average Shares
99.02%
1.0383
105.49 104.94 95.13 93.81
Basic Earnings Per Share
23.08%
-0.48
-0.39 -0.34 -0.43 -0.36
Diluted Earnings Per Share
23.08%
-0.48
-0.39 -0.34 -0.43 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):